US-64 net sales up in year 2001
Mumbai—Inspite of the woes of US-64, UTI’s flagship scheme investors seem to be determined to put their money in it. Ranked as the third-most popular instrument by investors in a NCAER-Sebi survey, sales of the scheme rose by 30 per cent increase in the fiscal year ended March 31, 2001 to Rs 4,230.76 crore, as compared to Rs 3,257.4 crore for the year ended March 31, 2000.
In the same period repurchases under the scheme declined by 21.6 per cent to Rs 2,119.35 crore as compared to Rs 2,703.43 crore for FY-00.
Consequently net sales (the difference between gross sales and repurchase) under the scheme, perked up to Rs 2,111.41 crore in 2000-01 compared to Rs 553.97 crore in 1999-00.

UTI’s net sales under all schemes for the fiscal year 2001 were Rs 323 crore only. This means that net sales under US-64 actually more than compensated for the outflows posted by other schemes.
Most of the net inflows into US-64 seem to have occurred in the April-June 2000 period after which net sales declined. Data sourced from UTI pertaining to the July 2000 to May 2001 period show that net sales under US-64 were negative at Rs 622.21 crore.
Back to News Review index page